The antiphospholipid syndrome.
Singapore Med J
; 33(5): 514-6, 1992 Oct.
Article
em En
| MEDLINE
| ID: mdl-1455280
ABSTRACT
The antiphospholipid syndrome (APS) describes an entity characterised by recurrent thrombosis, recurrent spontaneous abortions, thrombocytopenia, and elevated levels of antiphospholipid antibodies (IgG or IgM). The clinical features of APS include manifestations of thrombosis and/or cell damage. There is usually an associated underlying connective tissue disorder. The primary antiphospholipid syndrome refers to the presence of these clinical features without evidence of an associated autoimmune disorder. Detection of these antibodies include the lupus anticoagulant test, VDRL test and assays for anticardiolipin antibodies. Overlapping populations of these antibodies are detected by various immunologic tests. Management is based on the use of immunosuppressives, platelet inhibitors and anticoagulants.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Síndrome Antifosfolipídica
Limite:
Humans
Idioma:
En
Ano de publicação:
1992
Tipo de documento:
Article